These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
225 related articles for article (PubMed ID: 36091054)
1. Comprehensive analyses identify RIPOR2 as a genomic instability-associated immune prognostic biomarker in cervical cancer. Xu F; Zou C; Gao Y; Shen J; Liu T; He Q; Li S; Xu S Front Immunol; 2022; 13():930488. PubMed ID: 36091054 [TBL] [Abstract][Full Text] [Related]
2. Comprehensive Analyses Identify APOBEC3A as a Genomic Instability-Associated Immune Prognostic Biomarker in Ovarian Cancer. Xu F; Liu T; Zhou Z; Zou C; Xu S Front Immunol; 2021; 12():749369. PubMed ID: 34745121 [TBL] [Abstract][Full Text] [Related]
3. CX3CR1 Acts as a Protective Biomarker in the Tumor Microenvironment of Colorectal Cancer. Yue Y; Zhang Q; Sun Z Front Immunol; 2021; 12():758040. PubMed ID: 35140706 [TBL] [Abstract][Full Text] [Related]
4. [CD40LG is a novel immune- and stroma-related prognostic biomarker in the tumor microenvironment of invasive breast cancer]. Guo L; Ma Y; Li T; Li J Nan Fang Yi Ke Da Xue Xue Bao; 2022 Sep; 42(9):1267-1278. PubMed ID: 36210698 [TBL] [Abstract][Full Text] [Related]
5. A tumor microenvironment-related risk model for predicting the prognosis and tumor immunity of breast cancer patients. Geng S; Fu Y; Fu S; Wu K Front Immunol; 2022; 13():927565. PubMed ID: 36059555 [TBL] [Abstract][Full Text] [Related]
6. CD2 Is a Novel Immune-Related Prognostic Biomarker of Invasive Breast Carcinoma That Modulates the Tumor Microenvironment. Chen Y; Meng Z; Zhang L; Liu F Front Immunol; 2021; 12():664845. PubMed ID: 33968066 [TBL] [Abstract][Full Text] [Related]
7. Integrated Bioinformatical Analysis Identifies GIMAP4 as an Immune-Related Prognostic Biomarker Associated With Remodeling in Cervical Cancer Tumor Microenvironment. Xu F; Shen J; Xu S Front Cell Dev Biol; 2021; 9():637400. PubMed ID: 33553190 [TBL] [Abstract][Full Text] [Related]
8. Tumor microenvironment characterization in cervical cancer identifies prognostic relevant gene signatures. Peng L; Hayatullah G; Zhou H; Chang S; Liu L; Qiu H; Duan X; Han L PLoS One; 2021; 16(4):e0249374. PubMed ID: 33901225 [TBL] [Abstract][Full Text] [Related]
9. KCNN4 is a potential prognostic marker and critical factor affecting the immune status of the tumor microenvironment in kidney renal clear cell carcinoma. Chen S; Wang C; Su X; Dai X; Li S; Mo Z Transl Androl Urol; 2021 Jun; 10(6):2454-2470. PubMed ID: 34295732 [TBL] [Abstract][Full Text] [Related]
10. Mining of immunological and prognostic-related biomarker for cervical cancer based on immune cell signatures. Wang N; Nanding A; Jia X; Wang Y; Yang C; Fan J; Dong A; Zheng G; Ma J; Shi X; Yang Y Front Immunol; 2022; 13():993118. PubMed ID: 36341424 [TBL] [Abstract][Full Text] [Related]
11. Computational construction of TME-related lncRNAs signature for predicting prognosis and immunotherapy response in clear cell renal cell carcinoma. Zhou L; Fang H; Guo F; Yin M; Long H; Weng G J Clin Lab Anal; 2022 Aug; 36(8):e24582. PubMed ID: 35808868 [TBL] [Abstract][Full Text] [Related]
12. Construction of an immune-related gene signature for prediction of prognosis in patients with cervical cancer. Mei J; Xing Y; Lv J; Gu D; Pan J; Zhang Y; Liu J Int Immunopharmacol; 2020 Nov; 88():106882. PubMed ID: 32799114 [TBL] [Abstract][Full Text] [Related]
13. Identification of prognosis-related genes in the cervical cancer immune microenvironment. Yang L; Yang Y; Meng M; Wang W; He S; Zhao Y; Gao H; Tang W; Liu S; Lin Z; Li L; Hou Z Gene; 2021 Jan; 766():145119. PubMed ID: 32946928 [TBL] [Abstract][Full Text] [Related]
14. Identification of Tumor Microenvironment and DNA Methylation-Related Prognostic Signature for Predicting Clinical Outcomes and Therapeutic Responses in Cervical Cancer. Liu B; Zhai J; Wang W; Liu T; Liu C; Zhu X; Wang Q; Tian W; Zhang F Front Mol Biosci; 2022; 9():872932. PubMed ID: 35517856 [No Abstract] [Full Text] [Related]
15. Identification of Prognostic Related Genes of Tumor Microenvironment Derived From Esophageal Cancer Patients. Yuan W; Yan J; Liu H; Li L; Wu B; Guo C; Zhang M Pathol Oncol Res; 2021; 27():589662. PubMed ID: 34257539 [No Abstract] [Full Text] [Related]
16. Oncogenic signaling pathway-related long non-coding RNAs for predicting prognosis and immunotherapy response in breast cancer. Li H; Liu H; Hao Q; Liu X; Yao Y; Cao M Front Immunol; 2022; 13():891175. PubMed ID: 35990668 [TBL] [Abstract][Full Text] [Related]
17. N6-Methyladenosine-Related lncRNAs as potential biomarkers for predicting prognoses and immune responses in patients with cervical cancer. Zhang H; Kong W; Zhao X; Han C; Liu T; Li J; Song D BMC Genom Data; 2022 Jan; 23(1):8. PubMed ID: 35042477 [TBL] [Abstract][Full Text] [Related]
18. A comprehensive study of oxidative stress-related effects on the prognosis and drug therapy of cervical cancer. Sheng N; He C; Jin X; Meng Q; Gu P; Ding S; Liu H; Xu Y J Gene Med; 2024 Jan; 26(1):e3581. PubMed ID: 37605936 [TBL] [Abstract][Full Text] [Related]
19. Identification of a Tumor Microenvironment-Related Gene Signature Indicative of Disease Prognosis and Treatment Response in Colon Cancer. Chen W; Huang J; Xiong J; Fu P; Chen C; Liu Y; Li Z; Jie Z; Cao Y Oxid Med Cell Longev; 2021; 2021():6290261. PubMed ID: 34497681 [TBL] [Abstract][Full Text] [Related]
20. A Novel Prognostic Risk Model for Cervical Cancer Based on Immune Checkpoint HLA-G-Driven Differentially Expressed Genes. Xu HH; Wang HL; Xing TJ; Wang XQ Front Immunol; 2022; 13():851622. PubMed ID: 35924232 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]